GSE168526
Novel human-derived RET fusion NSCLC cell lines have heterogeneous responses to RET inhibitors and differential regulation of downstream signaling
The goal of this study was to understand RET signaling dynamics and regulation of response to RET inhibitors Overall design: RNAsequencing was preformed to determine differences in gene expression between RET-rearranged cell lines as well as changes after treatment with RET inhibitors